Skip to main content
Mark Eisner, MD, Gastroenterology, Zephyrhills, FL

Mark Eisner MD


Physician

Join to View Full Profile
  • 38135 Market SquareZephyrhills, FL 33542

  • Phone+1 813-780-7534

  • Fax+1 813-715-1810

Dr. Eisner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Gastroenterology, 1988 - 1990
  • Johns Hopkins University/Bayview Medical Center
    Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1985 - 1988
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1985

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1990 - 2026
  • MD State Medical License
    MD State Medical License 1986 - 1990
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2012

Press Mentions

  • Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
    Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis DeltaDecember 12th, 2024
  • Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency
    Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines AgencyNovember 18th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: